BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Eisai Corporation of North America 

500 Frank West Burr Boulevard
Suite 46
Teaneck  New Jersey  07666  U.S.A.
Phone: 201-692-8128 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






 Company News
Eisai Inc. (ESALF.PK) to Present New Research on Product Portfolio and Pipeline at American Society of Clinical Oncology Annual Meeting 5/19/2011 9:51:22 AM    More...
Eisai Corporation of North America Release: FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS) 7/8/2009 8:07:04 AM    More...
Eisai Corporation of North America and Pfizer Inc. (PFE) Decide not to Appeal NICE Decision and Call for an Expedited Review of Guidance for Alzheimer's Disease 7/1/2009 7:08:09 AM    More...
Morphotek Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer 3/23/2009 7:29:44 AM    More...
FDA Approves Eisai Corporation of North America's LUSEDRA(TM) Injection for Monitored Anesthesia Care (MAC) Sedation 12/15/2008 6:30:59 AM    More...
FDA Approves Eisai Corporation of North America's BANZEL(TM) (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder 11/17/2008 6:58:56 AM    More...
Morphotek Inc. Expands Its Phase II Trial Site Selections in the European Union 8/26/2008 8:06:43 AM    More...
FDA Approves Eisai Corporation of North America's ALOXI(R) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 8/25/2008 7:10:59 AM    More...
Morphotek Inc. Announces License Agreement for the Development of a Monoclonal Antibody to Treat Prostate Cancer 8/13/2008 8:43:16 AM    More...
Eisai Corporation of North America Receives Action Letter on Fospropofol Disodium Injection for Sedation in Diagnostic or Therapeutic Procedures; FDA's Not Approvable Letter Outlines Pathway to Potential Approval 7/28/2008 6:18:24 AM    More...
12

//-->